Male Breast Cancer is Most Strongly Associated with BRCA2 Gene
Male breast cancer is most strongly associated with the BRCA2 gene, with a lifetime risk of up to 8% in carriers, compared to only 1.2% for BRCA1 carriers. 1
Genetic Associations with Male Breast Cancer
BRCA2 - Primary Association
- BRCA2 mutations confer the highest risk for male breast cancer:
BRCA1 - Secondary Association
- BRCA1 mutations are associated with male breast cancer but at significantly lower rates:
Other Genetic Associations
- Other genes associated with male breast cancer include:
Risk Modifiers in Male Breast Cancer
- Risk can be substantially increased in BRCA2 carriers with:
Clinical Implications
- All male breast cancer patients should be offered genetic counseling and testing for germline mutations 1
- Annual mammography or ultrasound screening should be considered in male BRCA2 carriers with additional high-risk features from age 50 or 10 years before the earliest male breast cancer in the family 1
- Male BRCA2 carriers should be encouraged to be aware of physical changes in the breast and seek medical attention accordingly 1
Pathological Features
- BRCA2-associated male breast cancers tend to be of higher grade than sporadic male breast cancers 6
- BRCA2 male breast cancers are more likely to be estrogen receptor-positive and progesterone receptor-positive compared to BRCA2 female breast cancers 6
In conclusion, while multiple genes can contribute to male breast cancer risk, the BRCA2 gene shows the strongest and most consistent association, with substantially higher risk than BRCA1 or other breast cancer susceptibility genes.